Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
MwdFK1Bz54yL2kuC
Écouter
